In particular, the previous reports indicate that enhancing the infiltration of anti-inflammatory CD4+ T cells such as Treg while reducing the number of proinflammatory CD4+ T cells such as Th1 and Th17 could be a key element in improving AD inflammation; this hypothesis is also known to correct the Th17/Treg balance. Here, CD4 is linked to Alzheimer disease.